The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Lilly O.; Novartis
Consulting or Advisory Role - Lilly O.; Novartis
Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC).
 
Hyo S. Han
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Immunomedics; Immunomedics/Gilead; Novartis
Speakers' Bureau - Lilly
Research Funding - Abbvie (Inst); Arvinas (Inst); Department of Defense (Inst); G1 Therapeutics (Inst); GlaxoSmithKline (Inst); Horizon Oncology Research (Inst); Marker Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Phoenix Pharmaceuticals (Inst); QuantumLeap Health (Inst); Seagen (Inst); Zymeworks (Inst)
 
Ricardo L Costa
Stock and Other Ownership Interests - Dare Bioscience; Spero Therapeutics
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Pfizer; Sermonix Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Pfizer; Sermonix Pharmaceuticals
 
Hatem Hussein Soliman
Consulting or Advisory Role - AstraZeneca; GE Healthcare; Novartis; Puma Biotechnology; Seagen
Speakers' Bureau - Merck
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - Celeyad licensing agreement (Inst)
 
Aixa Soyano
No Relationships to Disclose
 
Hung T. Khong
Stock and Other Ownership Interests - agenus; Lipocine; MEI Pharma; MustangBio; TG Therapeutics; Tiziana Life Sciences; Vaxart
Consulting or Advisory Role - Celcuity
Research Funding - AstraZeneca
 
Loretta S. Loftus
Stock and Other Ownership Interests - Abbvie; Amgen; Gilead Sciences; Johnson & Johnson; Lilly O.; Pfizer
Consulting or Advisory Role - Cardinal Health
Travel, Accommodations, Expenses - Cardinal Health
 
Kimberley T Lee
No Relationships to Disclose
 
Avan J. Armaghani
No Relationships to Disclose
 
Hien Liu
No Relationships to Disclose
 
Jessica Malka
No Relationships to Disclose
 
Frederick L. Locke
Consulting or Advisory Role - A2 Biotherapeutics; Alimera Sciences; Amgen; Bluebird Bio; Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene; Calibr; Caribou Biosciences; Celgene; Cowen; Daiichi Sankyo/UCB Japan; EcoR1 Capital; Gerson Lehrman Group; Iovance Biotherapeutics; Janssen; Kite, a Gilead company; Legend Biotech; Miltenyi Biotec; Novartis; Sana Biotechnology; Takeda; Takeda; Umoja Biopharma; Umoja Biopharma
Research Funding - Alimera Sciences (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb/Celgene (Inst); Kite, a Gilead company (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - CAR T Cells with Enhanced Metabolic Fitness. Serial Number: 62/939,727 (Inst); Double Mutant Survivin Vaccine. US010414810B2. (Inst); Evolutionary Dynamics of Non-Hodgkin Lymphoma CAR-T cell therapy. Serial Number: 62/879,534. (Inst); Methods of Enhancing CAR T Cell Therapies. Serial Number: 62/892,292. (Inst)
Travel, Accommodations, Expenses - A2 Biotherapeutics; Kite, a Gilead company
 
Qianxing Mo
No Relationships to Disclose
 
Junmin Whiting
No Relationships to Disclose
 
Lavakumar Karyampudi
No Relationships to Disclose
 
Elizabeth E. Evans
Employment - Vaccinex
Leadership - Vaccinex
Stock and Other Ownership Interests - Vaccinex
Honoraria - University of Rochester
Patents, Royalties, Other Intellectual Property - Inventor on following patents: Treatment of cancer with a semaphorin-4d antibody in combination with an epigenetic modulating agent. U.S. Provisional Patent Application No. 62/473,731 Use of Semaphorin-4D inhibitory molecules in combination with an im (Inst)
 
Terrence Lee Fisher
Employment - Vaccinex
Stock and Other Ownership Interests - Vaccinex
Patents, Royalties, Other Intellectual Property - Patent author, Vaccinex, Inc.
 
Maurice Zauderer
Employment - Vaccinex
Leadership - Vaccinex
Stock and Other Ownership Interests - Vaccinex
Patents, Royalties, Other Intellectual Property - inventor on several patents assigned to Vaccinex, Inc. No royalty or other direct financial interest in patent.
 
Brian J. Czerniecki
Research Funding - Turnstone Bio
Patents, Royalties, Other Intellectual Property - ImmunoRestoration